Código QR (código de barras bidimensional)

Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks

Abstract Background Lebrikizumab demonstrated significant improvement versus placebo for measures of skin clearance and patient-reported outcomes at weeks 16 and 52 in patients with moderate-to-severe atopic dermatitis (AD). We report the sustained impact of lebrikizumab monotherapy, over 52 weeks a...

Fuld beskrivelse

Na minha lista:
Principais autores: Gil Yosipovitch, Peter Lio, Franz J. Legat, Raj Chovatiya, Mette Deleuran, Evangeline Pierce, Marta Casillas, Yuxin Ding, Fan E. Yang, Laia Bardolet, Sonja Ständer
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2024-07-01
Serier:Dermatology and Therapy
Fag:
Atopic dermatitis
Itch
Lebrikizumab
Sleep
POEM
Online adgang:https://doi.org/10.1007/s13555-024-01225-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker